Gov't Urged Not To Break Patents To Lower Drug Prices
The federal government should refrain from exercising its "march-in" rights to break patents for expensive drugs, a Washington-based think tank said Tuesday, warning that doing so may put the U.S. on...To view the full article, register now.
Already a subscriber? Click here to view full article